As reported, CCL18 could promote the migration, invasion, EMT and metastasis of the breast cancer and hepatocellular carcinoma cells through the phosphorylation of PyK2 or NF-κB signaling pathway [16, 18]. Here, NFKB1 is linked to hepatocellular carcinoma.